Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Review of Anticancer Therapy|July 22, 2010
Should we follow-up serum testosterone in patients with advanced prostate cancer?Massimo PerachinoBJU International|September 15, 2009
Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?Massimo Perachino, Valerio Cavalli, Fabio BraviTumori|June 25, 2010
Anti-androgen therapy suspension following prolonged clinical and biochemical response: outcomes in a series of elderly patients with advanced prostate cancerBruno Castagneto, Ilaria Stevani, Valentino Ferraris, et al.Current Medical Research and Opinion|June 26, 2007
Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summarySebastiano Spatafora, Giario Conti, Massimo Perachino, et al.Therapeutic Advances in Urology|December 4, 2012
Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.itSebastiano Spatafora, Antonio Casarico, Andrea Fandella, et al.Urology|April 10, 2014
Maximal testosterone suppression in prostate cancer--free vs total testosteroneKyle O Rove, E David Crawford, Massimo Perachino, et al.Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|November 29, 2007
Quality of life evaluation by the EORTC QLQ-C30 questionnaire in patients treated with hormonal treatment in Italy. A QuABIOS group studyDomenico Prezioso, Riccardo Bartoletti, Massimo Cecchi, et al.Pageof 1